Orange Book product · Brand (NDA)
MINOLIRA
MINOCYCLINE HYDROCHLORIDE
At a glance
May 08, 2017
Approved
Brand (NDA)
Application
Not listed
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 08, 2017
9 yr 3 mo ago
Today
Patent 11103517 expires
Listed drug product patent expiration.
Apr 07, 2036
in 9 yr 11 mo
Pharmaceutical detail
Active ingredient
MINOCYCLINE HYDROCHLORIDE
Strength
EQ 105MG BASE
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
TE code
Not listed
Application
NDA 209269
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- 2024EMROSIBrand (NDA)
NDA 219015 · JOURNEY
- 2020ZILXIBrand (NDA)
NDA 213690 · JOURNEY
- 2019AMZEEQBrand (NDA)
NDA 212379 · JOURNEY
- 2012XIMINOBrand (NDA)
NDA 201922 · JOURNEY
- 2006SOLODYNBrand (NDA)
NDA 050808 · BAUSCH
- 2001ARESTINBrand (NDA)
NDA 050781 · ORAPHARMA
- 1990MINOCINBrand (NDA)
NDA 050649 · BAUSCH
- 1982MINOCYCLINE HYDROCHLORIDEBrand (NDA)
NDA 050451 · TRIAX PHARMS
- —MINOCINBrand (NDA)
NDA 050315 · TRIAX PHARMS
- —MINOCINBrand (NDA)
NDA 050444 · REMPEX
- —MINOCINBrand (NDA)
NDA 050445 · BAUSCH
- 2022MINOCYCLINE HYDROCHLORIDEGeneric (ANDA)
ANDA 215466 · REGCON HOLDINGS
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 11103517 | Apr 07, 2036 | in 9 yr 11 mo | Product |

